BILL ANALYSIS

HR165

NEUTRAL

Wounded Knee Massacre Memorial and Sacred Site Act

HR165 (Wounded Knee Massacre Memorial and Sacred Site Act) has been assessed with a neutral outlook for investors. The primary sectors impacted are Real Estate. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

The bill is a land transfer with zero federal spending.

No publicly traded companies are impacted.

The legislation is already signed into law with no further market-moving potential.

How HR165 Affects the Market

This bill has no market implications. It does not authorize spending, create contracts, or affect any sector or publicly traded company. Retail investors should ignore this legislation for portfolio decisions.

Bill Details

Metric	Value
Bill Number	HR165
Market Sentiment	neutral
Event Date	December 19, 2025
Affected Sectors	Real Estate
Affected Stocks	N/A
Source	View on Congress.gov →

Summary

The Wounded Knee Massacre Memorial and Sacred Site Act (HR165) was signed into law on December 19, 2025. It directs the Department of the Interior to place approximately 40 acres of land in South Dakota into restricted fee status for the Oglala Sioux and Cheyenne River Sioux Tribes. The bill authorizes no federal spending and has no direct impact on publicly traded companies.

Full AI Market Analysis

The Wounded Knee Massacre Memorial and Sacred Site Act was signed into law on December 19, 2025, as Public Law 119-61. The bill directs the Secretary of the Interior to complete all actions necessary to place approximately 40 acres of land in Oglala Lakota County, South Dakota, into restricted fee status for the Oglala Sioux Tribe and Cheyenne River Sioux Tribe. The land is to be held as a memorial and sacred site. The bill authorizes no federal spending; it is a land status change only. There are no contracts, grants, tax credits, or procurement opportunities created by this legislation. No publicly traded companies are affected. The bill passed the House 416-0 and was enacted without controversy. It has no market implications.